subscribe Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Subscribe now
Picture: 123RF/KENG PO LEUNG
Picture: 123RF/KENG PO LEUNG

Steven Schultz from Momentum chose Adcock Ingram as his stock pick of the day.

“My stock is Adcock Ingram, well known for Panado, it currently has about 65% of its revenue from prescriptions and over-the-counter meds and around 25% from hospital drug usage. It’s significantly derated this year and went down around 29% over the past 12 months.”

Steven Schultz from Momentum talks to Business Day TV about his stock pick of the day

subscribe Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Subscribe now

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.